<p>当香港贸易分销行业近一半的公司市销率（或称 &#34;P/S&#34;）低于 0.6 倍时，您可能会考虑将 <strong>承辉国际</strong>（HKG:1094）视为一个潜在的避开对象，因为其市销率为 2.4 倍。尽管如此，仅仅将市销率表面化并不明智，因为可能有解释说明其为何如此之高。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>查看我们对承辉国际的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/7655421-ps-multiple-vs-industry-1-dark-2/1764024738192?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/7655421-ps-multiple-vs-industry-1-dark-2/1764024738192"/></p>
<p>SEHK:1094 市销率与行业比较 2025 年 11 月 24 日</p>
<h3>承辉国际的表现如何</h3>
<p>例如，考虑到承辉国际最近的财务表现不佳，其收入一直在下降。也许市场相信该公司能够在不久的将来超越行业其他公司，这使得市销率保持在高位。你真的希望如此，否则你就是在为没有特别理由的高价买单。</p>
<p>我们没有分析师的预测，但您可以通过查看我们关于承辉国际的 <strong>免费</strong> 报告，了解最近的趋势如何为公司未来铺路，包括其收益、收入和现金流。</p>
<h2>承辉国际的收入增长趋势如何？</h2>
<p>为了证明其市销率的合理性，承辉国际需要实现超过行业的显著增长。</p>
<p>回顾过去一年，公司收入出现了令人沮丧的 87% 的下降。过去三年也不容乐观，因为公司总共缩减了 12% 的收入。因此，可以公平地说，最近的收入增长对公司来说是不可取的。</p>
<p>与行业相比，预计在未来 12 个月内行业将实现 5.1% 的增长，而公司基于最近中期收入结果的下行趋势则显得格外严峻。</p>
<p>考虑到这一点，我们发现承辉国际的市销率超过其行业同行令人担忧。似乎大多数投资者忽视了最近糟糕的增长率，并寄希望于公司业务前景的好转。只有最勇敢的人才会认为这些价格是可持续的，因为最近收入趋势的持续可能会对股价产生重大压力。</p>
<h2>我们可以从承辉国际的市销率中学到什么？</h2>
<p>我们认为市销率的作用并不仅仅是作为估值工具，而是用来衡量当前投资者情绪和未来预期。</p>
<p>我们已经确定承辉国际目前的市销率远高于预期，因为其最近的收入在中期内一直在下降。当我们看到收入下滑并且表现不及行业预期时，我们感到股价下跌的可能性非常真实，这将使市销率回归合理范围。除非最近的中期条件显著改善，否则投资者将很难接受当前股价为公允价值。</p>
<p>您需要注意风险，例如——<strong>承辉国际有 3 个警告信号</strong>（其中 1 个令人担忧），我们认为您应该了解。</p>
<p>如果您对承辉国际的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的基本面稳健的其他公司呢？</p>

承辉国际

<p>承辉国际（HKG:1094）的市销率为 2.4 倍，远高于行业平均水平的 0.6 倍，尽管其收入正在下降。该公司的近期财务表现不佳，去年收入减少了 87%，三年来下降了 12%。如果情况不改善，高市销率可能无法持续，可能导致股价下跌</p>

<p>When close to half the companies in the Trade Distributors industry in Hong Kong have price-to-sales ratios (or &#34;P/S&#34;) below 0.6x, you may consider <strong>Cherish Sunshine International Limited</strong>(HKG:1094) as a stock to potentially avoid with its 2.4x P/S ratio. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's as high as it is.</p>
<div class="lb-trans"><p>当香港贸易分销行业近一半的公司市销率（或称 &#34;P/S&#34;）低于 0.6 倍时，您可能会考虑将 <strong>承辉国际</strong>（HKG:1094）视为一个潜在的避开对象，因为其市销率为 2.4 倍。尽管如此，仅仅将市销率表面化并不明智，因为可能有解释说明其为何如此之高。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>See our latest analysis for Cherish Sunshine International</p>
<div class="lb-trans"><p>查看我们对承辉国际的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/7655421-ps-multiple-vs-industry-1-dark-2/1764024738192" alt="" original-src="https://images.simplywall.st/asset/chart/7655421-ps-multiple-vs-industry-1-dark-2/1764024738192"/></p>
<p>SEHK:1094 Price to Sales Ratio vs Industry November 24th 2025</p>
<div class="lb-trans"><p>SEHK:1094 市销率与行业比较 2025 年 11 月 24 日</p>
</div><h3>How Cherish Sunshine International Has Been Performing</h3>
<div class="lb-trans"><h3>承辉国际的表现如何</h3>
</div><p>For example, consider that Cherish Sunshine International's financial performance has been poor lately as its revenue has been in decline. Perhaps the market believes the company can do enough to outperform the rest of the industry in the near future, which is keeping the P/S ratio high. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.</p>
<div class="lb-trans"><p>例如，考虑到承辉国际最近的财务表现不佳，其收入一直在下降。也许市场相信该公司能够在不久的将来超越行业其他公司，这使得市销率保持在高位。你真的希望如此，否则你就是在为没有特别理由的高价买单。</p>
</div><p>We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our <strong>free</strong> report on Cherish Sunshine International's earnings, revenue and cash flow.</p>
<div class="lb-trans"><p>我们没有分析师的预测，但您可以通过查看我们关于承辉国际的 <strong>免费</strong> 报告，了解最近的趋势如何为公司未来铺路，包括其收益、收入和现金流。</p>
</div><h2>How Is Cherish Sunshine International's Revenue Growth Trending?</h2>
<div class="lb-trans"><h2>承辉国际的收入增长趋势如何？</h2>
</div><p>In order to justify its P/S ratio, Cherish Sunshine International would need to produce impressive growth in excess of the industry.</p>
<div class="lb-trans"><p>为了证明其市销率的合理性，承辉国际需要实现超过行业的显著增长。</p>
</div><p>Retrospectively, the last year delivered a frustrating 87% decrease to the company's top line. The last three years don't look nice either as the company has shrunk revenue by 12% in aggregate. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.</p>
<div class="lb-trans"><p>回顾过去一年，公司收入出现了令人沮丧的 87% 的下降。过去三年也不容乐观，因为公司总共缩减了 12% 的收入。因此，可以公平地说，最近的收入增长对公司来说是不可取的。</p>
</div><p>Comparing that to the industry, which is predicted to deliver 5.1% growth in the next 12 months, the company's downward momentum based on recent medium-term revenue results is a sobering picture.</p>
<div class="lb-trans"><p>与行业相比，预计在未来 12 个月内行业将实现 5.1% 的增长，而公司基于最近中期收入结果的下行趋势则显得格外严峻。</p>
</div><p>With this in mind, we find it worrying that Cherish Sunshine International's P/S exceeds that of its industry peers. It seems most investors are ignoring the recent poor growth rate and are hoping for a turnaround in the company's business prospects. Only the boldest would assume these prices are sustainable as a continuation of recent revenue trends is likely to weigh heavily on the share price eventually.</p>
<div class="lb-trans"><p>考虑到这一点，我们发现承辉国际的市销率超过其行业同行令人担忧。似乎大多数投资者忽视了最近糟糕的增长率，并寄希望于公司业务前景的好转。只有最勇敢的人才会认为这些价格是可持续的，因为最近收入趋势的持续可能会对股价产生重大压力。</p>
</div><h2>What We Can Learn From Cherish Sunshine International's P/S?</h2>
<div class="lb-trans"><h2>我们可以从承辉国际的市销率中学到什么？</h2>
</div><p>We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.</p>
<div class="lb-trans"><p>我们认为市销率的作用并不仅仅是作为估值工具，而是用来衡量当前投资者情绪和未来预期。</p>
</div><p>We've established that Cherish Sunshine International currently trades on a much higher than expected P/S since its recent revenues have been in decline over the medium-term. When we see revenue heading backwards and underperforming the industry forecasts, we feel the possibility of the share price declining is very real, bringing the P/S back into the realm of reasonability. Unless the recent medium-term conditions improve markedly, investors will have a hard time accepting the share price as fair value.</p>
<div class="lb-trans"><p>我们已经确定承辉国际目前的市销率远高于预期，因为其最近的收入在中期内一直在下降。当我们看到收入下滑并且表现不及行业预期时，我们感到股价下跌的可能性非常真实，这将使市销率回归合理范围。除非最近的中期条件显著改善，否则投资者将很难接受当前股价为公允价值。</p>
</div><p>You need to take note of risks, for example - <strong>Cherish Sunshine International has 3 warning signs</strong> (and 1 which is concerning) we think you should know about.</p>
<div class="lb-trans"><p>您需要注意风险，例如——<strong>承辉国际有 3 个警告信号</strong>（其中 1 个令人担忧），我们认为您应该了解。</p>
</div><p>If you're <strong>unsure about the strength of Cherish Sunshine International's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您对承辉国际的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的基本面稳健的其他公司呢？</p>
</div>

承辉国际有限公司（HKG:1094）的股价似乎不太合理